321 related articles for article (PubMed ID: 7714509)
41. A family study of DSM-III-R schizoaffective disorder, depressive type, compared with schizophrenia and psychotic and nonpsychotic major depression.
Maj M; Starace F; Pirozzi R
Am J Psychiatry; 1991 May; 148(5):612-6. PubMed ID: 2018162
[TBL] [Abstract][Full Text] [Related]
42. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
Carey KB; Cocco KM; Simons JS
Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
[TBL] [Abstract][Full Text] [Related]
43. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
Kirkpatrick B; Amador XF; Flaum M; Yale SA; Gorman JM; Carpenter WT; Tohen M; McGlashan T
Schizophr Res; 1996 May; 20(1-2):69-77. PubMed ID: 8794495
[TBL] [Abstract][Full Text] [Related]
44. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey.
Kendler KS; Gallagher TJ; Abelson JM; Kessler RC
Arch Gen Psychiatry; 1996 Nov; 53(11):1022-31. PubMed ID: 8911225
[TBL] [Abstract][Full Text] [Related]
45. [Validation of diagnoses according to psychiatric diagnostic manuals in follow-up studies, exemplified by affective and schizophrenic diseases].
Maier W; Sandmann J
Nervenarzt; 1993 Mar; 64(3):160-8. PubMed ID: 8479586
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.
Fusar-Poli P; Cappucciati M; Rutigliano G; Heslin M; Stahl D; Brittenden Z; Caverzasi E; McGuire P; Carpenter WT
Schizophr Bull; 2016 Nov; 42(6):1395-1406. PubMed ID: 26980142
[TBL] [Abstract][Full Text] [Related]
47. McLean OnTrack: a transdiagnostic program for early intervention in first-episode psychosis.
Shinn AK; Bolton KW; Karmacharya R; Lewandowski KE; Yuksel C; Baker JT; Chouinard VA; Pingali SM; Bye H; Cederbaum K; Öngür D
Early Interv Psychiatry; 2017 Feb; 11(1):83-90. PubMed ID: 26616380
[TBL] [Abstract][Full Text] [Related]
48. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses.
Caton CL; Drake RE; Hasin DS; Dominguez B; Shrout PE; Samet S; Schanzer B
Arch Gen Psychiatry; 2005 Feb; 62(2):137-45. PubMed ID: 15699290
[TBL] [Abstract][Full Text] [Related]
49. Clinical characteristics influencing age at onset in psychotic disorders.
Ongür D; Lin L; Cohen BM
Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
[TBL] [Abstract][Full Text] [Related]
50. Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses.
Murray V; McKee I; Miller PM; Young D; Muir WJ; Pelosi AJ; Blackwood DH
Psychol Med; 2005 Apr; 35(4):499-510. PubMed ID: 15856720
[TBL] [Abstract][Full Text] [Related]
51. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
52. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
[TBL] [Abstract][Full Text] [Related]
53. The McLean-Harvard First-Episode Project: Early Course in 114 Cases of First-Episode Nonaffective Psychoses.
Tohen M; Khalsa HM; Salvatore P; Zarate CA; Strakowski SM; Sanchez-Toledo JP; Baldessarini RJ
J Clin Psychiatry; 2016 Jun; 77(6):781-8. PubMed ID: 27232651
[TBL] [Abstract][Full Text] [Related]
54. Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up.
Mauri MC; Di Pace C; Reggiori A; Paletta S; Colasanti A
Asian J Psychiatr; 2017 Oct; 29():117-122. PubMed ID: 29061407
[TBL] [Abstract][Full Text] [Related]
55. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
Møller T; Linaker OM
Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
[TBL] [Abstract][Full Text] [Related]
56. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
Peralta V; Cuesta MJ
J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
[TBL] [Abstract][Full Text] [Related]
57. The New York High-Risk Project. Psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up.
Erlenmeyer-Kimling L; Squires-Wheeler E; Adamo UH; Bassett AS; Cornblatt BA; Kestenbaum CJ; Rock D; Roberts SA; Gottesman II
Arch Gen Psychiatry; 1995 Oct; 52(10):857-65. PubMed ID: 7575106
[TBL] [Abstract][Full Text] [Related]
58. [Descriptive approach to latent forms of schizophrenia].
Rivet B; Bougerol T; Cura B; Llorca PM; Lançon C; Scotto JC
Encephale; 1994; 20(1):17-25. PubMed ID: 8174507
[TBL] [Abstract][Full Text] [Related]
59. On the descriptive validity of DSM III schizophrenia.
Fabrega H; Ahn C; Mezzich JE
Psychopathology; 1992; 25(2):79-89. PubMed ID: 1502295
[TBL] [Abstract][Full Text] [Related]
60. Chronology of comorbid and principal syndromes in first-episode psychosis.
Strakowski SM; Keck PE; McElroy SL; Lonczak HS; West SA
Compr Psychiatry; 1995; 36(2):106-12. PubMed ID: 7758295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]